Warby Parker Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WRBY research report →
Range $28 – $32
Price Chart
About the company
Warby Parker Inc. operates as a purveyor of optical products and related services. Their extensive product line includes prescription eyeglasses, sunglasses, and contact lenses, alongside specialized lens options such as light-responsive (photochromic) and blue-light-filtering variants.
- CEO
- Neil Harris Blumenthal
- IPO
- 2021
- Employees
- 4,036
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on WRBY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.52B
- P/E
- 443.17
- Fwd P/E
- 54.75
- PEG
- 0.27
- P/S
- 3.10
- P/B
- 8.22
- EV/EBITDA
- 43.68
- Div Yield
- 0.00%
- Gross Margin
- 54.75%
- Op Margin
- 0.16%
- Net Margin
- 0.80%
- ROE
- 1.94%
- ROIC
- 0.17%
Latest fiscal year · YoY change
- Revenue
- $871.90M+13.0%
- Gross Profit
- $470.58M+10.2%
- Op Income
- $-5,336,000
- Net Income
- $1.64M+108.0%
- EPS
- $0.01+107.9%
- OCF Growth
- +12.2%
- FCF Growth
- +26.0%
- 52W High
- $31.75
- 52W Low
- $16.95
- 50D MA
- $25.50
- 200D MA
- $25.13
- Beta
- 1.95
- RSI (14)
- 43
- Avg Volume
- 3.55M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Warby Parker delivered 10.4% Q3 revenue growth ahead of guidance, raised full-year outlook modestly, and is positioning intelligent eyewear as a 2027 growth catalyst.· November 5, 2026
- Q3 revenue rose 10.4% to $244.7 million, with adjusted EBITDA of $28.6 million and adjusted EBITDA margin of 11.7%.
- Gross margin improved to 54.6% of revenue, up 40 basis points, helped by lower tariffs, shipping optimization, lab efficiencies, and higher progressive/lens-treatment mix.
- Store expansion continued: 12 net new stores in Q3, 41 year to date, and management still expects 50 openings in 2026.
- Ecommerce growth reaccelerated to 5% as the home try-on headwind faded; eye exams grew 30% and insurance revenue 22% year over year.
- Management repeatedly said intelligent eyewear will contribute only modestly in 2026 but could become a meaningful revenue and profit driver beginning in 2027.
Third quarter revenue was $244.7 million, up 10.4% year over year; retail revenue increased 12.4% year over year and ecommerce revenue was $61.7 million, up 4.8%. Adjusted gross margin was 54.6% of revenue, or $133.6 million, up 40 basis points versus last year. Adjusted SG&A was $120.8 million, or 49.4% of revenue, up 70 basis points year over year. Adjusted EBITDA was $28.6 million, or 11.7% of revenue, up 10 basis points year over year. The company ended Q3 with $288 million in cash. For full-year 2026, management narrowed revenue guidance to $966 million to $976 million, implying about 11% to 12% growth, and adjusted EBITDA guidance to $117 million to $119 million. For Q4, it guided to revenue of $243 million to $253 million, or about 15% to 20% growth, and adjusted EBITDA of $26 million to $28 million. Management said guidance now includes a modest contribution from intelligent eyewear, with up to 1 percentage point to full-year revenue growth and several percentage points to Q4 growth.
The co-CEOs framed 2026 as a year of deliberate investment ahead of a larger product cycle, with intelligent eyewear at the center. David Gilboa said the company is focusing on launching the product well, getting demos in stores, and building awareness, while Neil Blumenthal emphasized Warby Parker’s store footprint, optometry network, and vertical integration as competitive advantages for a new category. Their tone was upbeat and confident, but they stressed that 2026 is mainly about product acceptance and preparation for a bigger 2027 ramp.
Adrian Mitchell highlighted that profitability held up despite launch-related spending, with Q3 adjusted gross margin at 54.6%, adjusted SG&A at 49.4% of revenue, and adjusted EBITDA at 11.7% of revenue. He said cash ended at $288 million and free cash flow was affected by higher capex to prepare stores and optical labs for intelligent eyewear, plus timing of partner reimbursements. He also noted a $5.6 million investment in an optical lens technology company and a commitment to fund R&D for new lenses over the next 2 years. On guidance, he said the company is being prudent because of the launch and current category softness, while still expecting 2026 revenue of $966 million to $976 million and adjusted EBITDA of $117 million to $119 million.
Analysts focused on the cadence of core demand, the size of the intelligent eyewear launch opportunity, and how much of Q4 guidance reflects launch costs versus base-business performance. Management said September was slightly softer but has since moderated, and that the industry remains weak on units, with pressure mostly from traffic rather than conversion. On intelligent eyewear, they said deliveries start in mid-December so 2026 revenue contribution will be modest, while 2027 should see a meaningful scale-up. They also said the guidance does not assume any halo from intelligent eyewear traffic, though they expect demos, marketing, and the launch to lift awareness and customer acquisition over time.
The company is seeing solid momentum in the parts of the business it has invested in for years: eye exams up 30%, insurance up 22%, and ecommerce growth back to 5%. Management believes intelligent eyewear could expand the addressable market and meaningfully improve growth and profitability starting in 2027. They also pointed to stronger conversion, higher average order value, and a large store network as advantages for launching a new category.
Management repeatedly acknowledged a choppy consumer backdrop, softer traffic, and industry-wide unit pressure that is weighing on new-customer growth. Q4 margins are expected to step down as marketing and launch-related spending rises, and the company said it is taking a prudent guidance stance because there are still unknowns around the launch. Intelligent eyewear is expected to contribute only modestly in 2026 because deliveries begin in mid-December, so near-term impact is limited.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 89.5%
- Shares Outstanding
- 108.80M
- Float Shares
- 97.36M
of shares held by institutions
331 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Fmr LLC | 16.25M | ▲ 677.07K |
| Blackrock, Inc. | 15.30M | ▼ 10.96K |
| Jpmorgan Chase & Co | 11.32M | ▲ 206.77K |
| Vanguard Group Inc | 10.62M | ▼ 43.65K |
| Vanguard Portfolio Management LLC | 6.01M | ▲ 24.86K |
| Durable Capital Partners LP | 4.99M | ▼ 1.41M |
| Vanguard Capital Management LLC | 4.51M | ▲ 21.05K |
| State Street Corp | 4.21M | ▲ 23.87K |
| Srs Investment Management, LLC | 3.40M | ▲ 1.95M |
| Vaughan Nelson Investment Management, L.P. | 2.75M | ▼ 360.77K |
| Geode Capital Management, LLC | 2.57M | ▲ 3.04K |
| Fuller & Thaler Asset Management, Inc. | 2.57M | ▲ 167.97K |
Held by 309 ETFs
Biggest fund positions in WRBY by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 9, 26 | Blumenthal Neil Harris | other | 73,133 |
| Nov 9, 26 | Blumenthal Neil Harris | other | 73,133 |
| Nov 9, 26 | Blumenthal Neil Harris | sell | 73,133 |
| Nov 9, 26 | Gilboa David Abraham | other | 75,402 |
| Nov 9, 26 | Gilboa David Abraham | other | 75,402 |
| Nov 9, 26 | Gilboa David Abraham | other | 75,402 |
| Nov 9, 26 | Gilboa David Abraham | other | 75,402 |
| Nov 9, 26 | Gilboa David Abraham | sell | 75,402 |
| Nov 9, 26 | Raider Jeffrey Jacob | sell | 7,500 |
| Nov 3, 26 | Blumenthal Neil Harris | other | 310,759 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our WRBY coverage
Recent articles, reports, and earnings notes.
No research on WRBY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WRBY report →What Google got right with the new Intelligent Eyewear launch with Warby Parker and Gentle Monster
youtube.com · Nov 13
Warby Parker bets on Google AI glasses for growth, but privacy fears still loom
reuters.com · Nov 12
Warby Parker's rival to Meta glasses is here. I got an early look.
businessinsider.com · Nov 12
Warby Parker Opens Preorders for First Intelligent Eyewear Collection
businesswire.com · Nov 12
What Warby Parker (WRBY) Said on Its Q3 Earnings Call
marketbeat.com · Nov 8
Warby Parker (WRBY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com · Nov 6
Why Warby Parker Stock Popped Today
fool.com · Nov 5
Warby Parker Inc. (WRBY) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.